No definition available.
Other congenital malformations of circulatory system
EFO MESH Endpoint Browser PheWeb
Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
911 |
4. Check minimum number of eventsNone |
911 |
5. Include endpointsNone |
911 |
6. Filter based on genotype QC (FinnGen only) |
911 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q2
- Name in latin
- Aliae malformationes congenitae systematis circulatorii
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of circulatory system
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the circulatory system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5679 | 2954 | 2695 |
| Only index persons | 5251 | 2773 | 2478 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | 0.08 |
| Only index persons | 0.10 | 0.10 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 50.81 | 51.53 | 50.08 |
| Only index persons | 51.08 | 51.74 | 50.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 911 | 525 | 386 |
| Unadjusted period prevalence (%) | 0.18 | 0.18 | 0.17 |
| Median age at first event (years) | 53.93 | 51.63 | 57.06 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 817
- Matched controls
- 8169
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
+∞
323.0
339
*
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
+∞
323.0
443
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
52.2
106.9
128
29
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.7
94.7
226
345
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
54.6
88.5
105
22
AAC40
NOMESCO Finland
Extirpation of intracranial arterio-venous malformation
+∞
76.3
72
*
AA1AD
NOMESCO Finland
CT of head and brain
4.4
73.2
338
1120
Q28.8
ICD-10 Finland
Other specified congenital malformations of circulatory system
+∞
67.7
64
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
27.9
66.8
92
37
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
12.6
61.5
114
104
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.4
60.0
141
199
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
16.4
52.5
86
58
PA2JT
NOMESCO Finland
Very extensive embolisation of arterio-venous malformation of the brain
+∞
48.4
46
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.9
47.8
232
752
PA2HT
NOMESCO Finland
Extensive embolisation of arterio-venous malformation of the brain
+∞
44.2
42
*
N03AF02
ATC
oxcarbazepine; oral
9.4
44.0
94
111
Q28.0
ICD-10 Finland
Arteriovenous malformation of precerebral vessels
+∞
41.0
39
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.8
40.8
148
358
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
59.4
38.7
45
8
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
13.4
38.4
68
55
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
27.1
37.2
51
20
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.5
35.3
67
63
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
81.9
35.1
39
5
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.0
34.6
81
111
XA800
NOMESCO Finland
Neuropsychological investigation
6.5
34.2
93
158
PA2GT
NOMESCO Finland
Embolisation of arterio-venous malformation of the brain
+∞
33.6
32
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
11.9
32.8
61
55
N03AF01
ATC
carbamazepine; oral, rectal
5.8
31.8
95
182
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
10.4
31.7
63
65
H93.1
ICD-10 Finland
Tinnitus
4.8
31.5
112
262
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
16.1
30.8
50
33
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
53.7
30.6
36
7
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
30.3
291
1439
D18.0
ICD-10 Finland
Haemangioma, any site
9.5
30.2
63
71
R51.80
ICD-10 Finland
Headache
3.2
29.6
181
674
Q28.1
ICD-10 Finland
Other malformations of precerebral vessels
+∞
29.3
28
*
N03AX14
ATC
levetiracetam; systemic
8.0
28.1
65
87
Q28.9
ICD-10 Finland
Congenital malformation of circulatory system, unspecified
+∞
27.2
26
*
XCK00
NOMESCO Finland
Perimetry
4.7
27.2
98
231
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
23.9
362
2181
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
23.4
341
2013
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.6
23.2
83
194
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
14.7
22.8
38
27
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
22.3
159
642
H53.4
ICD-10 Finland
Visual field defects
9.7
22.1
45
49
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
118.2
21.7
23
*
G40.10
ICD-10 Finland
Simple partial seizures
18.5
21.0
32
18
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.9
20.9
48
64
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
78.9
20.8
23
*
R4110
NOMESCO Finland
Physiotherapy
2.3
20.6
251
1345
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
17.5
20.6
32
19
XX4AW
NOMESCO Finland
NA
27.9
20.1
27
10
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
25.7
18.3
25
10
Z3226
NOMESCO Finland
Physiotherapist
2.4
18.2
179
860
Z2445
NOMESCO Finland
Psychologist
4.4
18.0
67
163
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
17.7
147
644
ZXD35
NOMESCO Finland
Usual procedure
5.1
17.1
54
111
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
16.2
91
312
Z3231
NOMESCO Finland
Registered nurse
2.0
16.2
250
1460
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
30.7
16.2
21
7
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
48.5
16.1
19
*
AAC30
NOMESCO Finland
Intracranial occlusion of vascular fistula
+∞
15.7
15
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
9.4
15.3
31
34
N03AX18
ATC
lacosamide; systemic
18.2
15.2
23
13
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
25.6
14.7
20
8
H53.2
ICD-10 Finland
Diplopia
4.8
14.5
48
104
WX002
NOMESCO Finland
Sedation and analgesia
2.1
14.4
179
950
N03AB02
ATC
phenytoin; systemic
10.3
14.0
27
27
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.8
13.9
60
168
PA5AC
NOMESCO Finland
Angiography of arteries to the face with X-ray
+∞
13.6
13
*
ZXC95
NOMESCO Finland
Use of surgical navigator
9.0
13.6
28
32
R20.2
ICD-10 Finland
Paraesthesia of skin
3.0
13.2
77
272
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
11.2
12.6
23
21
183
Kela drug reimbursment
Lamotrigin and topiramate
9.5
12.5
25
27
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
12.5
140
705
G44.2
ICD-10 Finland
Tension-type headache
2.2
12.3
131
645
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
38.2
12.2
15
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
12.2
143
735
N03AG01
ATC
valproic acid; systemic, rectal
3.0
12.2
70
244
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
11.3
12.1
22
20
R4150
NOMESCO Finland
Neuropsychological rehabilitation
10.3
12.0
23
23
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.8
12.0
81
312
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.2
11.9
62
202
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
47.4
11.9
14
*
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
11.3
11.6
21
19
Q27.3
ICD-10 Finland
Peripheral arteriovenous malformation
+∞
11.5
11
*
R4120
NOMESCO Finland
Occupational therapy
2.9
11.5
70
254
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.5
11.4
24
29
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
25.4
11.2
15
6
K90
ICPC
Stroke/cerebrovascular accident
5.7
11.1
31
56
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
8.7
11.1
23
27
XX4BW
NOMESCO Finland
NA
28.4
10.7
14
5
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.4
10.7
97
442
N18
ICPC
Paralysis/weakness
6.7
10.6
26
40
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
10.2
10.5
20
20
PA5JT
NOMESCO Finland
Embolisation of very extensive arterio-venous malformation of carotis externa area
+∞
10.4
10
*
AA9CW
NOMESCO Finland
NA
19.1
10.3
15
8
N02BE01
ATC
paracetamol; systemic, rectal
1.8
10.2
686
6040
K91
ICPC
Cerebrovascular disease
8.0
10.2
22
28
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
10.0
113
567
ZXD05
NOMESCO Finland
Urgent procedure
1.7
10.0
255
1716
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
6.6
9.8
24
37
WX882
NOMESCO Finland
High dependency care
4.3
9.8
35
84
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.3
9.5
47
149
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
17.8
9.4
14
8
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
30.4
9.4
12
*
G40
ICD-10 Finland
Epilepsy
8.2
9.4
20
25
R51
ICD-10 Finland
Headache
2.9
9.3
56
203
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.7
9.3
18
19
ZXE00
NOMESCO Finland
One hour or less
1.6
9.2
320
2333
H53.1
ICD-10 Finland
Subjective visual disturbances
2.7
9.2
63
248
WX892
NOMESCO Finland
Monitored bed care
2.5
9.1
69
287
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.2
9.1
47
154
WX110
NOMESCO Finland
Local anesthesy
1.6
8.9
544
4541
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
24.3
8.9
12
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.9
173
1066
N03AX09
ATC
lamotrigine; oral
2.9
8.6
50
178
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.8
8.5
35
96
ZX050
NOMESCO Finland
Stereotactic radiotherapy
7.5
8.5
19
26
Q82.2
ICD-10 Finland
Mastocytosis
91.0
8.4
9
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
8.3
8
*
N03AX16
ATC
pregabalin; oral
1.7
8.3
185
1189
G40.89
ICD-10 Finland
Other epilepsy
14.7
8.2
13
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
8.2
322
2399
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.6
8.2
60
246
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.4
8.2
68
297
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.5
8.0
59
242
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
22.3
8.0
11
5
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
8.0
75
347
AA5PD
NOMESCO Finland
CT examination of brain pefusion
7.9
7.9
17
22
R42
ICD-10 Finland
Dizziness and giddiness
1.8
7.9
159
990
AAF00
NOMESCO Finland
Ventriculostomy
8.6
7.8
16
19
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
10.9
7.8
14
13
Z2221
NOMESCO Finland
Medical doctor
1.6
7.8
225
1547
TAB00
NOMESCO Finland
Lumbar puncture
2.8
7.8
49
183
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
15.2
7.7
12
8
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.9
7.7
45
161
M79.6
ICD-10 Finland
Pain in limb
1.6
7.7
273
1978
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
7.6
180
1174
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.2
7.6
75
358
M03BX01
ATC
baclofen; systemic
4.9
7.5
23
48
PG1GT
NOMESCO Finland
Endovascular embolisation of arterio-venous malformation with radiological guidance not elsewhere classified
+∞
7.3
7
*
4301A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]
+∞
7.3
7
*
7478X
ICD-9 Finland
Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system
+∞
7.3
7
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
7.2
105
587
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
7.2
157
997
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
20.2
7.1
10
5
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
7.1
55
232
L28
ICPC
Limited function/disability (L)
1.9
7.0
108
614
ZXA00
NOMESCO Finland
Right side
1.6
7.0
198
1354
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.8
176
1172
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
11.1
6.8
12
11
N03AX12
ATC
gabapentin; oral
1.8
6.8
120
713
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
40.4
6.8
8
*
DFF00
NOMESCO Finland
Pure tone audiometry
2.2
6.7
69
336
RS222
NOMESCO Finland
NA
6.5
6.7
16
25
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.5
6.6
48
197
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
12.4
6.6
11
9
I63.8
ICD-10 Finland
Other cerebral infarction
8.8
6.6
13
15
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
7.5
6.4
14
19
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
6.4
52
227
PA2AD
NOMESCO Finland
CT angiography of brain
8.2
6.3
13
16
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
5.6
6.3
17
31
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
6.3
59
276
N05BA01
ATC
diazepam; systemic, rectal
1.8
6.3
104
604
R51.81
ICD-10 Finland
Facial pain NOS
4.4
6.3
21
49
PC6CC
NOMESCO Finland
Spinal angiography, very extensive
+∞
6.3
6
*
Q27.4
ICD-10 Finland
Congenital phlebectasia
+∞
6.3
6
*
Q27.9
ICD-10 Finland
Congenital malformation of peripheral vascular system, unspecified
+∞
6.3
6
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.6
6.2
26
74
I78.0
ICD-10 Finland
Hereditary haemorrhagic telangiectasia
26.9
6.2
8
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
6.3
6.2
15
24
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
7.8
6.1
13
17
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
5.0
6.1
18
37
ZXY02
NOMESCO Finland
Neuropsychologist
8.7
6.1
12
14
N05BA09
ATC
clobazam; oral
8.7
6.1
12
14
N28
ICPC
Limited function/disability (N)
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
103
52
22.21
136.07
1.8
1.8
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
157
373
4.88
62.74
8.7
11.0
mmol/l
24.4
24.4
0.06
151
352
(3033658) Prothrombin time (PT) actual/Normal
393
1876
2.93
53.20
5.9
3.9
%
94.0
92.4
0.67
381
1826
(3003396) Base excess in Arterial blood by calculation
218
787
3.33
47.50
8.5
8.9
mmol/l
0.9
1.2
0.42
162
634
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
216
785
3.30
46.46
8.5
8.9
kpa
5.1
5.1
0.36
209
758
(3027801) Oxygen [Partial pressure] in Arterial blood
216
785
3.30
46.46
8.5
8.9
kpa
17.3
12.6
12.38
209
760
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
411
2168
2.63
43.76
2.3
2.1
u/l
145.0
221.9
1.56
398
2047
(3044640) Blood type and Crossmatch panel - Blood
421
2332
2.50
39.35
2.6
2.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
42
39
11.24
39.33
2.5
2.4
umol/l
49.1
50.8
0.11
37
31
(3013826) Glucose [Moles/volume] in Serum or Plasma
623
4327
2.39
32.39
6.8
5.0
mmol/l
6.4
6.7
2.88
595
4044
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
329
1790
2.31
30.19
2.4
2.3
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
32
30
11.02
29.69
3.0
3.1
umol/l
28.4
34.6
1.10
24
22
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
503
3271
2.20
29.54
7.7
6.5
mmol/l
1.2
1.2
2.46
472
2975
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
526
3593
2.10
25.84
7.9
7.1
mmol/l
1.2
1.2
1.45
464
3058
(3036489) Thrombin time
93
283
3.55
25.82
3.1
2.2
s
21.9
21.5
0.26
85
260
(3032080) INR in Blood by Coagulation assay
438
2837
2.05
24.40
9.5
8.2
inr
1.2
1.2
0.11
120
844
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
500
3519
1.93
20.72
3.9
4.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
132
619
2.32
16.15
10.7
8.4
mmol/l
1.4
1.3
0.06
122
594
(36304419) Bacteria [Presence] in Urine
305
1956
1.84
15.71
4.0
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
310
2005
1.83
15.50
4.1
3.1
e6/l
0.4
0.5
0.30
240
1498
(3000991) Gas panel - Venous blood
124
588
2.28
14.73
12.2
9.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
206
1189
1.95
14.55
4.0
3.6
mmol/l
0.8
0.8
0.29
190
1122
(3044290) Cell count panel - Cerebral spinal fluid
52
159
3.41
14.28
2.7
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
229
1395
1.86
13.61
3.5
2.7
mosm/kgh2o
537.3
557.0
0.67
192
1192
(3002582) Erythrocytes [#/volume] in Urine
326
2212
1.74
13.44
4.1
3.2
e6/l
22.2
89.4
1.53
254
1694
(3018095) Leukocytes [#/volume] in Urine
370
2608
1.71
13.23
4.6
3.7
e6/l
56.4
91.2
0.97
269
1825
(3000850) Epithelial cells [#/volume] in Urine
237
1490
1.80
12.59
3.2
2.5
e6/l
5.2
6.0
0.46
206
1311
(3014576) Chloride [Moles/volume] in Serum or Plasma
159
886
1.96
12.28
10.0
7.6
mmol/l
105.4
104.1
2.77
159
866
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
205
1242
1.84
12.26
3.2
2.8
e6/l
1.4
1.1
0.77
124
713
(3016018) Differential panel - Cerebral spinal fluid
32
78
4.22
12.13
2.6
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
52
179
3.02
11.79
2.6
1.3
e6/l
18.8
10.5
0.24
38
139
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
52
179
3.02
11.79
2.6
1.4
e6/l
467.1
754.9
0.17
42
143
(3023368) Bacteria identified in Blood by Culture
282
1912
1.69
11.27
5.5
4.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
305
2112
1.67
11.24
3.8
4.0
ph
7.4
7.4
0.74
52
394
(4306422)
36
102
3.63
11.11
1.1
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
57
214
2.77
11.06
3.7
3.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
842
7642
2.34
10.90
18.6
13.4
mg/l
24.1
23.0
0.42
717
5952
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
54
205
2.74
10.27
3.9
2.9
u/ml
0.4
0.4
0.11
30
110
(40768804) Tissue Pathology biopsy report
400
3034
1.57
9.79
2.3
2.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
362
2711
1.56
9.22
3.4
3.4
ng/l
29.3
36.5
0.35
258
1816
(3019550) Sodium [Moles/volume] in Serum or Plasma
850
7827
2.28
9.21
21.8
15.1
mmol/l
139.5
139.7
0.95
837
7626
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
123
695
1.89
9.00
2.2
2.4
u/l
32.3
41.6
0.68
106
595
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
184
1174
1.71
8.96
3.5
2.9
e6/l
2.4
2.5
0.04
102
653
(3026008) Bacteria identified in Urine by Culture
293
2104
1.58
8.91
3.6
2.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
850
7849
2.24
8.77
21.6
15.2
mmol/l
3.9
4.0
2.14
836
7638
(3001604) Monocytes [#/volume] in Blood
474
3808
1.51
8.48
6.9
5.9
e9/l
0.6
0.6
0.04
401
3309
(3020779) Urea [Moles/volume] in Serum or Plasma
111
623
1.89
8.28
6.8
8.2
mmol/l
7.5
8.9
1.28
106
591
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
482
3898
1.50
8.27
6.8
6.5
umol/l
11.1
11.7
0.50
457
3695
(3003458) Phosphate [Moles/volume] in Serum or Plasma
154
955
1.74
8.27
5.3
6.0
mmol/l
1.0
1.0
0.05
140
889
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
34
113
3.09
8.23
1.4
1.2
u/ml
4.0
5.2
0.18
16
45
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
14
23
6.17
8.20
1.1
1.7
%
74.8
91.3
—
6
14
(3006315) Basophils [#/volume] in Blood
474
3827
1.50
8.16
7.0
6.0
e9/l
0.0
0.0
1.09
399
3331
(3023410) Appearance of Cerebral spinal fluid
30
93
3.30
8.13
3.6
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
337
2544
1.52
7.99
6.9
6.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
14
24
5.91
7.87
1.1
1.0
%
75.8
91.9
—
6
15
(3019198) Lymphocytes [#/volume] in Blood
480
3912
1.48
7.72
7.2
6.0
e9/l
1.9
1.9
0.16
406
3465
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
195
1310
1.62
7.70
3.3
3.6
ng/l
951.4
345.0
0.65
149
978
(3024561) Albumin [Mass/volume] in Serum or Plasma
393
3082
1.48
7.65
5.0
5.0
g/l
35.2
35.9
1.35
371
2879
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
33
115
2.94
7.39
1.0
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
421
3373
1.46
7.21
12.2
9.2
e9/l
0.0
0.0
0.46
328
2764
(3051611) Lipemic interference index of Serum or Plasma
24
70
3.49
7.15
3.5
3.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
70
353
2.06
7.09
7.3
4.8
mmol/l
23.7
24.2
0.65
64
317
(3013115) Eosinophils [#/volume] in Blood
480
3954
1.45
7.05
7.5
6.3
e9/l
0.2
0.2
0.14
410
3494
(3019069) Monocytes/100 leukocytes in Blood
440
3591
1.44
6.65
7.6
6.4
%
8.7
8.5
0.55
416
3372
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
79
3.23
6.60
2.3
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
437
3577
1.43
6.42
7.5
6.1
%
3.1
2.8
1.08
406
3339
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
138
890
1.65
6.34
3.6
2.9
umol/l
7.9
7.4
0.12
118
775
(3022096) Basophils/100 leukocytes in Blood
425
3467
1.42
6.33
7.5
6.1
%
0.7
0.7
1.01
400
3244
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
20
59
3.44
5.89
1.2
1.1
mg/l
231.3
228.4
0.04
20
54
(3018010) Neutrophils/100 leukocytes in Blood
439
3639
1.40
5.79
7.4
6.0
%
56.5
56.8
0.24
413
3418
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
651
5777
1.44
5.78
7.8
7.6
u/l
77.1
77.6
0.14
622
5423
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
30
114
2.69
5.78
1.4
1.2
u/ml
4.7
2.4
—
9
36
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
232
1715
1.47
5.77
2.4
1.8
mg/l
1.4
1.2
0.39
190
1291
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
25
86
2.96
5.76
1.0
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
443
3685
1.39
5.68
7.6
6.2
%
28.1
28.4
0.22
416
3446
(40761511) CBC panel - Blood by Automated count
851
8029
1.91
5.65
16.6
12.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
253
1915
1.44
5.53
9.9
6.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22
72
3.11
5.52
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
783
7237
1.58
5.46
16.6
12.0
ml/min/173m2
85.3
83.7
1.24
690
5924
(3002032) Base excess in Venous blood by calculation
102
634
1.69
5.39
6.4
4.5
mmol/l
1.2
2.0
0.93
90
502
(3036481) Cortisol [Moles/volume] in Serum or Plasma
115
738
1.64
5.38
2.2
2.0
nmol/l
380.6
364.6
0.39
108
688
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
67
369
1.88
5.32
13.9
12.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
130
865
1.59
5.24
14.4
20.5
inr
1.1
1.2
0.32
12
125
(3051651) Icteric interference index of Serum or Plasma
18
54
3.38
5.18
3.8
3.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
591
5203
1.39
5.14
3.5
3.1
u/l
47.8
47.1
0.07
559
4883
(3009466) Valproate [Moles/volume] in Serum or Plasma
31
129
2.45
5.01
3.9
5.2
umol/l
371.9
373.4
0.02
26
117
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
23
83
2.82
4.90
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
860
8189
1.90
4.82
11.7
10.2
u/l
27.7
26.5
0.32
827
7924
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
72
419
1.78
4.82
1.6
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
585
5169
1.37
4.80
4.8
4.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
628
5616
1.38
4.75
4.1
4.1
mm/h
10.1
11.3
1.68
595
5196
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
95
600
1.65
4.74
1.8
2.4
ug/l
4.6
7.5
1.68
82
543
(3011397) Hemoglobin [Presence] in Urine by Test strip
223
1694
1.42
4.69
3.5
3.5
—
—
—
0
0
(4268621)
22
80
2.79
4.64
2.7
2.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
134
2.36
4.64
1.9
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
134
2.36
4.64
1.9
1.3
—
—
—
0
0
(4027681)
17
53
3.25
4.63
1.2
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
593
5270
1.36
4.57
3.8
3.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
75
449
1.73
4.56
7.2
5.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
508
4412
1.34
4.55
10.8
9.3
e9/l
3.9
4.1
0.74
430
3873
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
71
422
1.74
4.43
1.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
352
2908
1.34
4.36
2.0
1.9
pmol/l
94.2
96.0
0.32
185
1530
(3003181) Sodium [Moles/volume] in Urine
28
119
2.40
4.36
1.8
1.3
mmol/l
89.7
60.9
1.58
23
102
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
755
7011
1.45
4.26
5.1
4.6
mu/l
1.8
2.1
0.75
710
6436
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
57
3.02
4.14
1.0
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
310
2529
1.34
4.13
3.7
3.4
u/l
34.5
31.5
0.38
299
2411
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
135
959
1.48
4.03
2.4
2.4
%
25.7
22.9
1.01
120
824
(3004789) Transferrin [Mass/volume] in Serum or Plasma
143
1030
1.46
3.97
2.3
2.4
g/l
2.2
2.3
1.25
133
960
(3042936) Bacteria identified in Isolate by Culture
150
1092
1.45
3.94
2.3
2.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
25
4.03
3.70
1.0
10.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
298
2450
1.32
3.69
3.5
3.4
mmol/l
2.4
2.4
0.08
260
2169
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
16
5.67
3.66
1.4
1.7
umol/l
18.2
17.9
—
9
16
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
35
3.46
3.62
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
30
143
2.14
3.62
1.1
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
107
744
1.50
3.55
3.8
3.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
26
3.88
3.53
1.0
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
9
17
5.34
3.51
1.1
1.0
mg/g
6.3
5.7
—
9
17
(3012441) Differential panel - Pleural fluid
16
58
2.79
3.43
2.3
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
14
47
3.01
3.42
1.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
18
5.04
3.37
1.1
1.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
37
3.27
3.35
1.3
4.5
umol/l
156.2
112.3
—
5
21
(3001122) Ferritin [Mass/volume] in Serum or Plasma
385
3317
1.28
3.26
2.9
2.8
ug/l
127.1
119.9
0.23
362
3083
(3022948) Iron [Moles/volume] in Serum or Plasma
148
1113
1.39
3.24
2.3
2.4
umol/l
14.0
13.3
0.44
138
1031
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
76
502
1.56
3.21
1.6
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
141
1054
1.40
3.20
1.3
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
697
6477
1.32
3.19
23.5
16.2
%
13.7
13.6
0.21
689
6348
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
169
1302
1.37
3.19
2.9
2.9
mmol/l
2.4
2.4
0.67
141
1155
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
15
5.37
3.19
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
108
770
1.46
3.17
3.5
2.8
%
1.9
1.8
0.27
97
699
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
44
2.98
3.14
2.9
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
8
7.54
3.06
1.2
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
883
8584
1.93
3.05
27.8
19.6
e9/l
251.1
252.3
0.22
865
8369
(3024731) MCV [Entitic volume]
883
8586
1.92
3.02
27.6
19.5
fl
90.7
90.8
0.07
875
8473
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
637
5867
1.29
3.00
4.3
3.9
pmol/l
14.7
14.7
0.21
596
5353
(3035941) MCH [Entitic mass]
883
8587
1.92
3.00
27.6
19.5
pg
30.3
30.3
0.03
875
8473
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
151
1154
1.37
3.00
1.9
1.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
883
8588
1.92
2.98
27.7
19.6
e12/l
4.5
4.5
2.42
864
8354
(3023520) Reticulocytes [#/volume] in Blood
83
569
1.50
2.97
3.7
2.6
e9/l
74.7
73.5
0.08
56
440
(3003338) MCHC [Mass/volume]
708
6615
1.32
2.97
24.5
17.1
g/l
333.1
332.9
0.29
703
6571
(3010813) Leukocytes [#/volume] in Blood
883
8590
1.91
2.95
27.7
19.6
e9/l
6.6
6.7
0.21
865
8349
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
13
46
2.85
2.92
1.0
1.0
u/l
1.0
1.1
—
6
25
(3023323) Follitropin [Units/volume] in Serum or Plasma
56
353
1.62
2.89
1.9
1.3
iu/l
30.3
26.9
0.28
49
301
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
13
5.42
2.87
1.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
416
3659
1.25
2.84
3.6
3.5
estimate
0.0
0.0
0.00
70
678
(3020891) Body temperature
46
278
1.69
2.79
7.9
4.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
205
1658
1.31
2.77
1.5
1.5
nmol/l
20.6
20.6
0.01
185
1412
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
6
8.37
2.75
1.0
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
88
621
1.46
2.75
3.9
2.7
g/l
10.4
10.4
0.04
80
576
(3000963) Hemoglobin [Mass/volume] in Blood
882
8590
1.84
2.74
27.9
19.7
g/l
134.6
136.3
2.86
875
8475
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
14
5.03
2.73
1.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
420
3711
1.24
2.72
3.7
3.5
estimate
0.0
0.0
0.80
68
660
(3007164) IgA [Mass/volume] in Serum or Plasma
195
1572
1.31
2.70
1.5
1.5
g/l
2.5
2.4
0.23
121
978
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
54
344
1.61
2.69
2.5
2.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
50
313
1.63
2.67
1.3
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
258
2161
1.27
2.64
1.4
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
97
703
1.43
2.64
2.6
2.5
g/l
0.2
0.2
0.03
90
663
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
25
3.63
2.58
1.0
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
80
562
1.46
2.57
3.8
4.1
mmol/l
1.2
1.2
0.79
70
492
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
50
2.62
2.54
1.0
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
414
3674
1.23
2.51
5.2
4.7
estimate
0.0
0.0
0.50
71
693
(3007853) Bacteria identified in Skin by Aerobe culture
118
893
1.37
2.50
1.8
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
28
151
1.88
2.49
2.1
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
15
63
2.40
2.47
2.1
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
51
2.57
2.45
1.8
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
103
766
1.39
2.43
4.6
4.4
u/l
242.2
252.6
0.30
96
728
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
67
461
1.49
2.40
3.8
3.5
pmol/l
4.5
4.6
0.68
62
413
(3024928) Oxygen saturation in Venous blood
27
146
1.88
2.39
7.1
4.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
37
221
1.70
2.38
2.0
1.3
u/l
11.0
9.5
0.21
29
178
(3017446) Testosterone [Moles/volume] in Serum or Plasma
80
573
1.43
2.34
3.1
2.2
nmol/l
14.3
13.3
0.35
74
512
(3014051) Protein [Presence] in Urine by Test strip
28
156
1.82
2.28
2.1
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
40
248
1.64
2.25
1.2
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
9
5.58
2.21
3.4
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
554
5107
1.22
2.19
3.1
3.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
48
2.52
2.19
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
24
3.35
2.18
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
24
3.35
2.18
1.0
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
14
4.31
2.15
1.0
3.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
36
220
1.66
2.15
1.6
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
71
506
1.44
2.15
2.0
2.9
ng/l
177.4
162.7
0.12
63
458
(3009542) Hematocrit [Volume Fraction] of Blood
747
7115
1.28
2.14
22.1
14.2
%
39.6
40.1
1.08
586
5332
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
37
229
1.64
2.11
2.4
1.8
nmol/l
43.2
38.0
0.40
37
219
(3024869) Neuronal Ab [Presence] in Serum
5
10
5.02
2.07
1.0
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
104
797
1.34
2.06
2.1
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
132
1.84
2.05
1.2
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
69
494
1.43
2.05
2.1
1.8
g/l
1.2
1.4
0.47
63
457
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
15
4.02
2.04
2.5
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
15
4.02
2.04
5.0
5.7
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
26
3.09
2.01
1.0
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
40
256
1.59
2.01
1.7
2.3
ug/l
378.2
301.5
0.28
40
239
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
213
1801
1.24
1.97
2.3
2.1
mg/l
2.6
3.0
1.63
183
1538
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
75
550
1.40
1.96
3.0
4.0
ng/l
80.1
82.3
0.07
67
492
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
51
2.37
1.95
1.7
1.5
u/l
12.0
4.5
—
7
24
(3017143) Hepatitis C virus Ab [Presence] in Serum
117
920
1.31
1.95
1.4
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
80
595
1.38
1.92
1.3
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
64
458
1.43
1.92
3.5
2.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
92
1.98
1.91
1.0
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
34
212
1.63
1.91
7.4
4.1
mmol/l
3.7
3.9
1.43
34
196
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
293
1.53
1.88
1.4
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
118
934
1.30
1.88
1.6
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
103
800
1.32
1.88
2.1
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
37
237
1.58
1.87
2.2
3.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
34
2.66
1.87
3.4
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
34
2.66
1.87
3.4
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
34
2.66
1.87
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
46
2.41
1.85
5.2
1.9
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
70
513
1.39
1.84
5.7
4.1
kpa
5.2
5.1
0.57
63
483
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
113
892
1.30
1.84
7.1
6.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
17
3.55
1.84
1.0
1.2
—
—
—
0
0
(4133840)
6
17
3.55
1.84
1.3
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
12
4.18
1.82
1.0
1.1
—
—
—
0
0
(4035726)
87
663
1.35
1.81
1.4
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
69
508
1.39
1.78
5.8
4.1
ph
7.4
7.4
—
7
63
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
79
596
1.36
1.76
2.7
2.6
ml/min/173m2
78.5
68.6
0.95
36
234
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
36
2.51
1.74
1.0
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
32
202
1.61
1.73
1.3
1.2
—
—
—
0
0
(4198724)
8
30
2.68
1.72
1.4
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
174
1461
1.24
1.71
1.7
1.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
16
82
1.97
1.70
1.3
1.2
u/l
52.7
53.7
—
9
60
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
268
2351
1.20
1.70
2.8
2.5
u/l
57.4
56.1
0.22
247
2174
(3024980) IgG subclass 4 [Mass/volume] in Serum
22
126
1.76
1.69
2.3
1.7
g/l
0.5
0.9
1.30
16
97
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
42
285
1.50
1.67
2.1
1.9
ug/l
3.4
2.3
0.21
36
261
(3047181) Lactate [Moles/volume] in Blood
32
204
1.59
1.67
6.6
9.1
mmol/l
1.2
1.3
0.33
27
183
(3015171) Extractable nuclear Ab [Units/volume] in Serum
42
286
1.49
1.65
1.2
1.2
u/ml
0.3
1.3
—
6
24
(3006184) Hemoglobin [Mass/volume] in Capillary blood
25
150
1.69
1.64
3.0
2.2
g/l
136.5
130.5
0.37
16
112
(3045788) Cell count panel - Pleural fluid
11
49
2.26
1.64
2.6
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
47
328
1.46
1.64
1.2
1.5
—
12.6
—
0
9
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40
270
1.50
1.64
1.4
1.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
20
113
1.79
1.61
1.4
1.5
nmol/l
0.2
0.4
0.70
15
95
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
26
2.71
1.58
7.9
4.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
221
1917
1.20
1.57
2.9
2.9
ng/l
796.4
1085.0
1.33
193
1617
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
41
281
1.48
1.57
1.6
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
92
1.86
1.56
1.9
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
8
33
2.44
1.54
1.5
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
345
3116
1.17
1.54
2.2
2.3
nmol/l
75.6
76.1
0.12
309
2818
(3006462) Nitrate [Presence] in Urine
7
27
2.60
1.51
3.0
3.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
108
1.78
1.51
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
234
2050
1.19
1.49
1.7
1.7
mmol/l
1.4
1.4
0.26
202
1727
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
143
1194
1.23
1.49
1.5
1.6
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
14
72
1.96
1.49
2.9
1.3
g/l
0.4
0.3
—
9
51
(3028192) IgG subclass 2 [Mass/volume] in Serum
14
72
1.96
1.49
2.9
1.3
g/l
3.0
2.7
—
9
51
(3027135) IgG subclass 1 [Mass/volume] in Serum
14
72
1.96
1.49
2.9
1.3
g/l
6.6
6.9
—
9
52
(3048689) Calprotectin [Mass/mass] in Stool
118
965
1.26
1.48
1.7
2.4
ug/g
177.7
117.0
0.38
92
774
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
37
2.45
1.48
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
116
948
1.26
1.47
1.3
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
45
2.24
1.46
1.7
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
77
597
1.32
1.46
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
130
1077
1.24
1.46
1.3
1.3
titre
264.4
488.2
2.43
18
225
(3006653) Thiamine [Moles/volume] in Blood
9
38
2.38
1.46
1.0
1.4
nmol/l
144.4
146.7
—
9
38
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
28
2.51
1.45
3.4
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
95
1.80
1.43
1.3
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
6
22
2.74
1.43
2.2
1.3
mmol/l
2.4
2.8
—
6
22
(3004588) Protein electrophoresis panel - Serum or Plasma
61
459
1.35
1.42
1.7
2.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
64
486
1.34
1.40
5.9
4.1
mmol/l
2.0
1.5
0.40
47
359
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
40
2.26
1.40
1.0
2.8
u/ml
627.1
742.7
—
9
40
(3004451) EKG impression Narrative
9
40
2.26
1.40
1.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
139
0.43
1.40
1.3
1.7
—
—
—
0
0
(4062490)
14
74
1.91
1.39
2.9
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
23
142
1.64
1.39
1.3
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
31
207
1.52
1.37
2.5
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
76
1.86
1.30
1.4
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
23
145
1.60
1.30
10.0
3.7
mmol/l
2.9
2.4
0.19
12
101
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
204
1788
1.18
1.29
1.3
1.3
u/ml
1.1
1.5
0.35
54
495
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
40
286
1.42
1.27
1.6
2.1
g/l
1.1
1.5
2.07
34
251
(3014271) Vancomycin [Susceptibility]
8
36
2.23
1.24
3.8
2.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
45
2.01
1.23
1.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
19
116
1.65
1.22
1.7
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
51
385
1.34
1.19
6.1
4.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
15
86
1.76
1.19
1.3
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
45
335
1.36
1.15
6.7
4.7
mmol/l
25.3
24.7
0.71
39
319
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
39
2.06
1.15
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
20
2.51
1.15
1.2
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
113
0.44
1.13
1.4
1.5
—
—
—
0
0
(4211845)
7
31
2.27
1.10
3.0
3.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
41
1.96
1.09
8.0
7.8
—
—
—
0
0
(3010421) pH of Blood
26
177
1.48
1.08
9.2
3.6
ph
7.4
7.4
0.49
21
142
(3036782) Glucose [Moles/volume] in Pleural fluid
11
59
1.87
1.07
2.0
1.3
mmol/l
6.8
6.5
0.09
11
54
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
157
1372
1.17
1.04
3.1
2.9
ug/l
0.7
0.7
0.74
108
874
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
9
46
1.97
1.03
1.8
6.3
—
48.5
—
0
11
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
793
7735
1.19
1.03
4.9
4.8
mmol/l
2.8
2.8
0.47
739
7156
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
2.0
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
65
520
1.27
1.03
1.3
1.3
u/ml
302.3
229.0
0.22
59
476
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
230
1.41
1.03
1.6
1.5
ug/g
353.3
300.6
0.85
22
143
(1761868) Lipid panel - Serum or Plasma
265
2897
0.88
1.00
2.6
2.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
134
0.52
0.99
1.1
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
21
140
1.51
0.98
9.4
3.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
762
7417
1.17
0.97
4.3
4.4
mmol/l
5.8
5.9
0.77
710
6800
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
36
1.95
0.97
2.1
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
22
149
1.49
0.96
1.1
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
45
347
1.31
0.95
3.9
3.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
194
1737
1.15
0.94
4.2
4.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
54
428
1.28
0.94
1.1
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
67
546
1.25
0.93
1.4
1.2
iu/ml
86.2
146.8
1.07
26
230
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
36
271
1.34
0.90
2.5
2.2
u/l
127.0
3752.4
1.71
16
109
(21494434) Karyotype in Bone marrow
12
71
1.70
0.89
1.2
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
42
1.91
0.88
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
42
1.91
0.88
1.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
13
79
1.65
0.88
1.1
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
169
1.43
0.88
2.2
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
56
1.79
0.88
1.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
95
1.59
0.87
1.1
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
255
1.35
0.87
1.7
2.6
g/l
4.0
3.7
0.61
28
187
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
255
1.35
0.87
1.7
2.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
75
624
1.22
0.87
3.3
4.4
%
1.4
1.0
0.22
22
197
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
717
6965
1.14
0.87
5.6
5.5
mmol/mol
38.5
39.6
2.82
679
6490
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
153
1.45
0.86
1.1
1.1
u/ml
0.1
2.6
—
9
63
(3023430) Cat dander IgE Ab [Units/volume] in Serum
16
104
1.55
0.85
1.1
1.0
u/ml
5.1
4.3
—
7
35
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
308
0.71
0.84
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
40
310
1.30
0.84
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
146
1.45
0.83
2.0
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
75
629
1.21
0.81
3.3
3.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
14
89
1.58
0.81
4.1
1.6
pg
32.4
32.7
0.07
14
89
(3013512) EKG study
231
2115
1.12
0.80
3.8
3.6
—
—
—
0
0
(4010399)
42
529
0.78
0.80
1.9
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
52
420
1.25
0.80
1.3
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
68
566
1.22
0.80
3.3
4.2
%
0.8
0.5
0.23
15
139
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
139
1.45
0.79
1.2
1.0
u/ml
9.7
5.3
0.48
12
67
(3027008) Opiates [Presence] in Urine
40
313
1.29
0.79
1.3
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
42
331
1.28
0.79
1.8
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
66
549
1.22
0.78
3.4
4.6
%
0.0
0.7
0.63
16
149
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
82
1.59
0.78
3.9
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
40
314
1.29
0.77
1.3
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
63
754
0.82
0.77
1.7
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
36
279
1.30
0.77
2.6
2.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
107
1.50
0.76
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
209
0.66
0.76
1.1
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
83
1.57
0.75
1.1
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
54
1.67
0.74
1.4
1.7
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
24
2.09
0.74
1.2
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
100
870
1.17
0.74
1.3
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
133
0.60
0.74
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
27
202
1.35
0.73
2.0
1.9
iu/l
1.9
5.2
—
9
67
(40761535) Cells panel - Urine sediment
71
600
1.20
0.73
3.2
3.5
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
15
100
1.51
0.73
1.0
1.9
—
1744.0
—
0
5
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
100
1.51
0.73
1.1
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
7
39
1.80
0.72
1.3
1.7
—
—
—
0
0
(44813793)
10
60
1.67
0.72
1.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
134
1.43
0.71
5.1
3.4
e9/l
3.9
4.4
0.34
19
134
(3011648) Oxygen content in Venous blood
9
57
1.58
0.71
18.4
6.6
%
9.6
10.6
—
9
57
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
26
1.93
0.70
3.8
2.1
ug/l
107.8
68.7
—
5
26
(3033799) Differential panel - Peritoneal fluid
5
26
1.93
0.70
2.4
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
113
997
1.15
0.70
1.8
1.8
%
1.5
1.5
0.32
101
886
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
93
1.51
0.69
1.4
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
69
585
1.19
0.69
3.4
4.5
%
0.1
0.1
0.13
19
178
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
157
0.63
0.69
1.8
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
26
341
0.76
0.69
1.2
1.7
mg/l
3.0
2.9
0.02
20
246
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
187
1.35
0.68
2.7
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
214
1971
1.11
0.68
3.9
3.8
estimate
0.0
0.0
1.08
69
672
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
43
1.63
0.67
1.4
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
15
214
0.70
0.67
1.0
1.1
—
7.0
—
0
32
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
38
305
1.26
0.64
1.5
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
37
296
1.26
0.64
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
292
0.75
0.64
1.0
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
95
1.48
0.64
1.4
1.2
nmol/l
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
112
1.44
0.63
1.1
1.0
u/ml
6.8
5.0
—
6
39
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
776
7615
1.13
0.63
4.4
4.3
mmol/l
4.7
4.7
0.48
724
7091
(3000475) Leukocytes [#/volume] in Synovial fluid
13
188
0.69
0.63
1.7
1.7
e6/l
5518.0
14909.1
—
6
143
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
138
1.38
0.63
5.4
3.8
%
57.8
57.4
0.06
19
138
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
244
1.28
0.62
1.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
191
1.32
0.61
2.6
1.8
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
50
1.61
0.61
1.1
1.2
ug/l
4.7
6.4
—
8
39
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
159
1450
1.12
0.61
1.4
1.5
—
—
—
0
0
(44806420)
0
20
0.00
0.60
0.0
2.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
163
0.67
0.60
4.3
3.8
mg/l
25.2
25.1
—
6
99
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
747
7321
1.11
0.60
4.1
3.9
mmol/l
1.3
1.3
0.52
693
6758
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
23
0.00
0.58
0.0
1.3
—
22.9
—
0
15
(3027456) Digoxin [Moles/volume] in Serum or Plasma
7
113
0.62
0.58
3.6
3.0
nmol/l
0.7
0.8
—
7
86
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
54
1.49
0.57
8.0
2.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
38
311
1.23
0.56
1.3
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
133
1.36
0.55
3.1
1.9
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
38
312
1.23
0.55
3.8
3.7
mmol/l
25.4
25.1
0.21
38
306
(40767503) Oxygen content in Capillary blood by calculation
19
142
1.35
0.54
3.7
2.4
%
17.2
16.4
0.29
13
72
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
82
1.47
0.54
1.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
2.7
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
2.7
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
202
1881
1.09
0.52
4.0
4.1
%
21.5
21.1
0.16
86
854
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
28
225
1.25
0.50
1.1
1.2
—
—
—
0
0
(44806118)
14
101
1.39
0.49
3.2
1.7
—
—
—
0
0
(44790048)
14
101
1.39
0.49
3.2
1.7
—
—
—
0
0
(44790047)
14
101
1.39
0.49
3.2
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
101
1.39
0.49
5.8
2.6
—
—
—
0
0
(44790049)
14
101
1.39
0.49
3.2
1.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
19
145
1.32
0.49
1.3
1.5
—
112.5
—
0
27
(3019225) pH of Specimen
80
711
1.14
0.48
2.9
4.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
28
226
1.25
0.48
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
16
119
1.35
0.48
2.3
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
68
1.48
0.47
3.1
1.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
68
1.48
0.47
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
117
0.68
0.46
1.9
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
118
0.68
0.46
1.9
2.8
u/ml
4.4
37.8
—
8
112
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
77
1.43
0.45
2.6
3.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
28
228
1.24
0.45
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
211
1.24
0.44
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
139
1.30
0.44
2.4
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
298
2842
1.07
0.44
3.9
3.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
769
7579
1.09
0.43
4.4
4.3
mmol/l
1.5
1.5
0.04
717
7022
(3023419) Bacteria identified in Sputum by Culture
14
104
1.35
0.43
3.0
2.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
17
131
1.30
0.42
1.1
1.1
u/ml
1.7
1.9
—
9
55
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
32
1.57
0.42
3.6
1.7
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
8.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
16
0.00
0.41
0.0
3.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
245
2327
1.07
0.40
4.8
4.7
ug/l
1.8
2.4
2.00
224
2102
(3017569) Oxygen content in Arterial blood
5
34
1.47
0.40
1.0
4.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
38
442
0.85
0.39
1.5
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
102
934
1.10
0.39
1.7
2.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
4.2
—
29.1
—
0
5
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
36
1.39
0.38
1.2
3.0
—
63809.0
—
0
7
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
37
1.35
0.37
1.4
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
18
143
1.26
0.37
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
180
1.23
0.36
3.4
2.5
ug/min
91.9
105.7
0.10
12
109
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
46
522
0.87
0.36
1.4
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
18
144
1.26
0.35
5.2
4.0
u/ml
138.8
1970.1
0.56
18
136
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
2.7
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
82
1.35
0.34
2.5
2.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
118
1.28
0.33
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
144
0.76
0.33
1.2
1.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
6
46
1.31
0.33
1.0
1.1
—
11.4
—
0
7
(21494755) Public health laboratory ask at order entry panel
75
820
0.91
0.32
1.4
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.2
1.4
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
6
47
1.28
0.32
1.0
1.0
ng/l
189.8
266.6
—
6
30
(3035285) Chloride [Moles/volume] in Venous blood
11
83
1.33
0.32
2.5
2.6
mmol/l
105.9
105.0
0.42
11
83
(3041354) Potassium [Moles/volume] in Venous blood
11
83
1.33
0.32
2.5
2.6
mmol/l
4.1
4.1
0.08
11
83
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
202
1.19
0.31
1.3
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
243
2329
1.06
0.31
3.2
3.2
mmol/l
8.3
7.8
0.73
206
1963
(3012516) Albumin [Mass/volume] in Urine
222
2122
1.06
0.31
3.4
3.3
mg/l
53.0
303.8
2.17
138
1357
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
52
1.35
0.31
1.0
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
172
1631
1.07
0.31
4.0
3.7
kg/l
1.0
1.0
0.17
19
207
(3019309) Folate [Moles/volume] in Red Blood Cells
132
1241
1.07
0.30
1.7
1.7
nmol/l
1022.5
1188.3
1.45
99
932
(3021901) Oxygen saturation in Capillary blood
16
129
1.24
0.30
4.4
2.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
55
1.27
0.30
3.4
2.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
79
728
1.09
0.29
4.1
4.5
ug/l
9.7
26.8
0.78
58
607
(3020682) Albumin/Creatinine [Ratio] in Urine
233
2237
1.06
0.28
4.0
4.0
mg/mmol
6.1
8.0
0.49
143
1412
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
76
1.32
0.28
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
76
1.32
0.28
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
76
1.32
0.28
1.2
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
85
1.30
0.28
1.0
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
246
0.85
0.26
1.4
1.6
iu/ml
0.1
0.1
—
8
41
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
73
0.68
0.26
1.0
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
19
160
1.19
0.25
1.3
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
75
1.20
0.25
1.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
76
1.19
0.24
2.1
2.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
96
1.25
0.24
6.6
4.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
81
755
1.08
0.24
1.5
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
29
255
1.14
0.24
1.4
1.9
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
83
0.72
0.24
1.3
2.4
—
23.4
—
0
21
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
28
247
1.14
0.23
1.2
1.3
miu/ml
216.5
249.4
0.21
16
115
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
191
1.16
0.22
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
22
191
1.16
0.22
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
30
267
1.13
0.22
1.7
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
172.0
—
0
11
(3052592) Norovirus Ag [Presence] in Stool
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
201
1.15
0.21
1.4
1.6
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
12.0
—
0
5
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
173
1.16
0.21
1.1
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
22
192
1.15
0.21
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
22
192
1.15
0.21
1.5
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
13
0.00
0.21
0.0
10.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
30
334
0.89
0.20
1.9
1.5
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
6
48
1.25
0.20
1.0
1.0
ng/l
770.7
614.7
—
6
31
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
23
202
1.14
0.20
1.3
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
114
0.79
0.20
1.1
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
83
879
0.94
0.19
1.9
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
52
1.15
0.19
2.5
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
142
1363
1.05
0.19
1.2
1.3
iu/ml
15.3
35.3
4.30
37
424
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
109
1.20
0.18
2.8
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
85
805
1.06
0.18
1.2
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
100
1.20
0.18
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
60
1.17
0.18
1.1
1.2
—
—
—
0
0
(4024509)
7
60
1.17
0.18
1.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
60
1.17
0.18
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
60
1.17
0.18
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
60
1.17
0.18
1.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
91
1.21
0.17
2.1
2.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
155
1495
1.04
0.17
1.5
1.6
pmol/l
447.0
38591302.8
1.92
133
1249
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
27
243
1.11
0.17
1.6
1.4
g/l
0.2
0.2
0.29
27
231
(3026389) Candida sp identified in Specimen by Organism specific culture
10
82
1.22
0.17
1.3
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
129
1.17
0.17
1.7
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
173
0.86
0.17
1.3
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
18
158
1.14
0.16
1.7
4.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
54
506
1.07
0.16
1.6
1.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
72
1.11
0.16
1.1
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
72
1.11
0.16
2.0
2.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
216
1.11
0.15
1.2
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
204
1985
1.04
0.15
2.9
2.7
umol/l
4486.2
6884.5
0.35
176
1733
(3039443) Prostate specific Ag panel - Serum or Plasma
14
161
0.87
0.15
1.6
1.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
131
1.15
0.14
7.2
3.6
u/ml
—
2514.4
—
0
11
(3041096) Erythrocytes [Presence] in Urine by Automated
198
2031
0.97
0.14
3.5
3.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
138
0.87
0.13
1.3
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
106
0.85
0.13
2.2
1.6
—
—
—
0
0
(4094501)
22
200
1.10
0.12
1.2
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
133
1.13
0.12
1.1
1.1
—
12.4
—
0
10
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
43
405
1.06
0.12
1.5
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
95
1.16
0.11
1.5
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
14
157
0.89
0.11
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
105
1.14
0.11
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
105
1.14
0.11
1.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
105
1.14
0.11
1.3
1.4
—
—
—
0
0
(1002224) Polysomnography panel
38
358
1.06
0.10
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
14
156
0.90
0.10
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
54
516
1.05
0.10
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
106
1.13
0.10
1.6
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
106
1.13
0.10
1.3
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
5
46
1.09
0.09
1.2
3.8
—
60.5
—
0
8
(3014599) Egg white IgE Ab [Units/volume] in Serum
6
56
1.07
0.08
1.0
1.2
—
2.6
—
0
19
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
107
1.12
0.08
1.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
107
1.12
0.08
1.3
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
61
0.82
0.08
1.8
1.6
—
—
—
0
0
(3000492) Spirometry study
80
776
1.03
0.08
1.5
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
65
1.08
0.08
1.9
1.6
g/l
0.9
1.0
—
7
65
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
128
1253
1.03
0.07
1.5
1.4
—
—
—
0
0
(4281824)
7
80
0.87
0.07
1.4
1.2
—
—
—
0
0
(4146454)
7
84
0.83
0.07
4.6
2.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
55
531
1.04
0.07
4.1
2.9
e9/l
3.7
4.1
0.77
43
423
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
23
216
1.07
0.07
1.3
2.2
mg/l
10.8
11.5
0.14
23
198
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
128
1.10
0.06
1.4
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
26
274
0.95
0.06
3.3
4.0
g/l
0.4
0.3
0.22
14
116
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
130
1.08
0.04
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
86
844
1.02
0.04
1.7
1.9
—
—
—
0
0
(4034850)
25
239
1.05
0.04
13.9
9.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
159
0.94
0.03
1.4
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
270
0.96
0.03
1.3
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
23
221
1.04
0.03
1.9
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
138
0.94
0.02
4.3
3.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
92
930
0.99
0.02
3.7
4.3
%
32.5
31.7
0.30
63
636
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
123
1.06
0.01
2.0
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
154
0.97
0.00
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
264
0.98
0.00
1.3
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
131
1305
1.00
0.00
1.3
1.3
u/ml
14.6
12.1
0.13
57
520
(40768793) Breast Pathology biopsy report
19
188
1.01
0.00
1.5
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
212
0.99
0.00
1.2
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
153
0.98
0.00
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
18
181
0.99
0.00
6.3
4.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
109
1.01
0.00
4.4
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
14
141
0.99
0.00
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
42
415
1.01
0.00
1.5
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
26
255
1.02
0.00
1.7
1.4
g/l
1.1
1.2
0.50
26
240
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
1.3
—
0.6
—
0
7
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
(3023511) Choriogonadotropin [Units/volume] in Urine
16
160
1.00
0.00
1.3
1.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
326.8
—
0
6
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.1
—
0
5
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
68
0.88
0.00
1.5
2.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
51
0.98
0.00
1.0
1.8
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
79
0.89
0.00
1.1
8.7
mmol/l
5.9
7.1
—
7
66
(3036525) Urea [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
11.3
—
0
9
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
65
0.92
0.00
1.0
1.2
—
70.4
—
0
7
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
170
1.00
0.00
1.4
1.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
8
0.00
0.00
0.0
2.5
—
296.5
—
0
8
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
10.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
3.0
—
7.2
—
0
7
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
178.8
—
0
6
(1617658) Protocol used for examination of sentinel lymph nodes
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
50
1.00
0.00
1.8
1.3
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM | 1.412 [1.2, 1.67] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.218 |
During the follow-up period (1.1.1998 — 31.12.2019), 247 out of 2415 females with Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM | 1.509 [1.28, 1.78] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.02 |
During the follow-up period (1.1.1998 — 31.12.2019), 309 out of 2209 males with Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.111% | 0.301% |
| 5 | 0.689% | 1.751% |
| 10 | 1.803% | 4.426% |
| 15 | 3.836% | 8.529% |
| 20 | 6.932% | 14.452% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM – Other congenital malformations of circulatory system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data